Live
RecursionA Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates - simplywall.st10x Genomics BlogWhy 10x Genomics (TXG) stock is down today - MSN10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.st10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves - simplywall.stMerck & Co.Merck & Co. Inc. stock (US58933Y1055): Earnings beat and pipeline update drive investor interest - AD HOC NEWSMettler ToledoMettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives - simplywall.stLabCorpLabcorp stock (US50540R4092): Diagnostic and drug development leader in focus for US investors - AD HOC NEWSCellFerroptosis inhibition enhances liver and lung graft functionCell<em>Streptomyces</em> enrichment in roots during drought is uncoupled from plant benefit and is driven by host suppression of iron uptake and immunityCellAI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathologyCellMultimodal clocks of human agingCellThe rise of polyploids during environmental upheaval
10x Genomics Blog Mar 25, 2026

10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares - MarketBeat

10x Genomics (NASDAQ:TXG) CEO Serge Saxonov Sells 10,000 Shares - MarketBeat

Original
Body unavailable. Use the original source.